Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$577 Hold
11
﹤0.01% 1015
2026
Q1
$607 Hold
11
﹤0.01% 1025
2025
Q4
$539 Hold
11
﹤0.01% 1425
2025
Q3
$475 Hold
11
﹤0.01% 1386
2025
Q2
$422 Hold
11
﹤0.01% 1433
2025
Q1
$426 Hold
11
﹤0.01% 1287
2024
Q4
$372 Hold
11
﹤0.01% 1302
2024
Q3
$450 Buy
+11
New +$450 ﹤0.01% 1460
2024
Q2
Sell
-63,370
Closed -$2.72M 1196
2024
Q1
$2.72M Buy
+63,370
New +$2.61M 0.01% 641

Other funds holding GSK

Danske Bank's GSK Position: Q2 2026 in Review

Danske Bank held its GSK (GSK) position steady in Q2 2026 at 11 shares worth $577. The position accounts for ﹤0.01% of the portfolio, ranked #1015.

Danske Bank first reported a position in GSK in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.72M in Q1 2024. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Danske Bank held 11 shares of GSK worth $577 as of Q2 2026.
  • Danske Bank left its GSK share count unchanged in Q2 2026.
  • GSK made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #1015 holding.
  • Danske Bank first reported a position in GSK in Q1 2024 and has held it in 9 quarters since.
  • Danske Bank's GSK position peaked at $2.72M in Q1 2024.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.